Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription Articles published in Eur J Radiol Retrieve available abstracts of 67 articles: HTML format

Single Articles

November 2026
1. NG N, Cabbabe K, Li Y, Li C, et al
   Implementing PI-QUAL in Clinical Practice: A Systematic Review of Reproducibility, Diagnostic Impact, and the Role of Education and Automation.
   Eur J Radiol. 2026;204:113115.
   PubMed     Abstract available
   
   
   
2. BAYRAKTAROGLU H, Heimer MM, Kuhnle JF, Lorbeer R, et al
   Validation of AI-derived whole prostate volumetry versus ellipsoid formula for PSA density-based risk stratification.
   Eur J Radiol. 2026;204:113080.
   PubMed     Abstract available
   
   
   October 2026
3. HUANG J, Zhang Y, Yang O, Feng Q, et al
   Periprostatic adipose tissue imaging in prostate cancer: Imaging phenotypes, task-specific spatial strategies, and multicompartment integration-a critical review.
   Eur J Radiol. 2026;206:113296.
   PubMed     Abstract available
   
   
   
4. KYLE ET, Sweeney KJ, McCabe DH, O'Sullivan NJ, et al
   MRI-derived radiomics for prostate cancer active surveillance: a systematic review.
   Eur J Radiol. 2026;205:113291.
   PubMed     Abstract available
   
   
   September 2026
5. TANG X, Chen M, Wu Y, Lin H, et al
   Incremental Value of Transrectal Ultrasound Target Visibility Beyond Clinical and MRI Variables for Predicting Biopsy-Detected Clinically Significant Prostate Cancer: Temporal and External Validation.
   Eur J Radiol. 2026;205:113255.
   PubMed     Abstract available
   
   
   
6. WUNSCH III DC, Esengur OT, Makwana RD, Harmon SA, et al
   Impact of MRI quality on the accuracy of targeted prostate biopsy: A prospective PI-QUAL analysis.
   Eur J Radiol. 2026;205:113254.
   PubMed     Abstract available
   
   
   
7. PAKPOOR J, Englman C, Adebusoye B, Cosenza M, et al
   Measuring prostate cancer lesion size on serial MRI during active surveillance: A multi-centre observational study.
   Eur J Radiol. 2026;206:113233.
   PubMed     Abstract available
   
   
   
8. LEE YJ, Choi MH, Grimm R, von Busch H, et al
   Performance of a deep learning algorithm on deep learning reconstruction-accelerated prostate biparametric MRI: A preliminary study.
   Eur J Radiol. 2026;205:113227.
   PubMed     Abstract available
   
   
   
9. VAN MOSSEL S, van der Velden KJM, Kleiburg F, Bosch D, et al
   Laying the groundwork for future health economic evaluation of [(18)F]PSMA PET/CT in guiding treatment decisions for metastatic castration-resistant prostate cancer patients.
   Eur J Radiol. 2026;205:113213.
   PubMed     Abstract available
   
   
   July 2026
10. CUMMINGS C, Allen C, Dickinson L, Pendse D, et al
    Can prostate cancer be diagnosed with near certainty on MRI?
    Eur J Radiol. 2026;204:113107.
    PubMed     Abstract available
    
    
    
11. BISCHOFF LM, Schmidt CJ, Endler C, Bernhardt M, et al
    Comparison of biparametric and multiparametric prostate MRI to assess extraprostatic tumor extension.
    Eur J Radiol. 2026;204:113110.
    PubMed     Abstract available
    
    
    June 2026
12. LEE YJ, Choi MH, Kim H, Jeong G, et al
    Vendor-neutral deep learning reconstruction of dynamic contrast-enhanced prostate MRI: Image quality improvement and preservation of diagnostic performance.
    Eur J Radiol. 2026;203:113020.
    PubMed     Abstract available
    
    
    
13. COELHO FMA, Mussi TC, Moreira LF, Vilas Boas IP, et al
    Limited reproducibility of PI-RADS v2.1 upgrading rule subcategorization in MRI-visible peripheral zone lesions: A lesion-level targeted-biopsy study.
    Eur J Radiol. 2026;203:113004.
    PubMed     Abstract available
    
    
    
14. HIGAKI A, Tamada T, Takeuchi M, Ueda Y, et al
    Impact of a commercial artificial intelligence decision-support system on biparametric MRI interpretation for detecting clinically significant prostate cancer: a retrospective single-center prostatectomy-validated multi-reader study across experience
    Eur J Radiol. 2026;203:112964.
    PubMed     Abstract available
    
    
    May 2026
15. ALTAN SA, Sakar R, Onay A, Kizil PG, et al
    Prostate imaging after focal ablation scoring after irreversible electroporation treatment in localized prostate cancer: Diagnostic accuracy and inter-reader agreement.
    Eur J Radiol. 2026;202:112948.
    PubMed     Abstract available
    
    
    
16. SINGH D, Salazar Gutierrez JP, Rouviere O, Giganti F, et al
    Use of Artificial Intelligence in prostate MRI: A rapid scoping review highlighting limited evidence in screening context.
    Eur J Radiol. 2026;202:112930.
    PubMed     Abstract available
    
    
    April 2026
17. KADIRLI K, Canturk A
    Real-world text-only inference of PI-RADS v2.1 from prostate MRI reports using large language models: a lesion-level, zone-aware study.
    Eur J Radiol. 2026;200:112838.
    PubMed     Abstract available
    
    
    March 2026
18. ZENG Y, Shen S, Ma H, Yin R, et al
    Early prediction via PET/CT for skeletal-related events in osteoporotic men with metastatic prostate cancer undergoing androgen deprivation therapy.
    Eur J Radiol. 2026;199:112822.
    PubMed     Abstract available
    
    
    
19. SONG JS, Jang W
    Prostate MRI quality assessment using PI-QUAL version 2: Comparative analysis between 1.5 T and 3 T scanners and its association with T-staging agreement.
    Eur J Radiol. 2026;199:112821.
    PubMed     Abstract available
    
    
    
20. WIBULPOLPRASERT P, Bihan DL, Leelarujijaroen P, Kampaengtip A, et al
    Potential of the signature index (S-index), a diffusion MRI Biomarker, to enhance diagnosis of clinically significant prostate cancer and decrease the rate of unnecessary biopsies.
    Eur J Radiol. 2026;199:112788.
    PubMed     Abstract available
    
    
    December 2025
21. XIANG F, Zeng Y, Zhang Z, Zhang Y, et al
    Predictive value of quantitative parameters from dual-tracer FDG and PSMA PET/CT for progression to castration resistance in patients with metastatic hormone-sensitive prostate cancer.
    Eur J Radiol. 2025;195:112614.
    PubMed     Abstract available
    
    
    November 2025
22. EHRENGUT C, Alberalar ND, Franz T, Horn LC, et al
    Evaluation of the TARGET score for MRI-based detection of prostate cancer recurrence in patients treated with HIFU hemiablation.
    Eur J Radiol. 2025;195:112572.
    PubMed     Abstract available
    
    
    
23. SHEN S, Liu B, Li Y, Zeng Y, et al
    mpMRI-based interpretable machine learning model for predicting castration-resistant prostate cancer risk.
    Eur J Radiol. 2025;195:112521.
    PubMed     Abstract available
    
    
    September 2025
24. YUN Y, Guo J, Shao N, Zhang X, et al
    Synthetic MRI as a T2WI alternative in bp-MRI: comparable image quality and improved PI-RADS performance.
    Eur J Radiol. 2025;193:112414.
    PubMed     Abstract available
    
    
    August 2025
25. ZHANG X, Shen H, Xu Q, Tu C, et al
    CT derived myocardial extracellular volume predict major adverse cardiovascular events in patients with prostate cancer.
    Eur J Radiol. 2025;192:112371.
    PubMed     Abstract available
    
    
    
26. AGROTIS G, Woo S, Jaderling F, Ursprung S, et al
    Radiological T-staging in prostate Cancer: Towards a universal MRI-based scoring system.
    Eur J Radiol. 2025;191:112363.
    PubMed     Abstract available
    
    
    July 2025
27. AGHAKHANYAN G, Barucci A, Pascali MA, Assante M, et al
    NAVIGATOR: A regional multimodal imaging biobank initiative powered by AI tools for precision medicine in oncology.
    Eur J Radiol. 2025;191:112327.
    PubMed     Abstract available
    
    
    
28. BRENDER JR, Ota M, Nguyen N, Ford JW, et al
    Predicting ADC map quality from T2-weighted MRI: A deep learning approach for early quality assessment to assist point-of-care.
    Eur J Radiol. 2025;191:112317.
    PubMed     Abstract available
    
    
    
29. CURIA B, Bortolotto C, Brizzi L, Santagostini S, et al
    Impact on MRI technologist of a PI-QUAL v2 educational program on prostate MRI image quality assessment.
    Eur J Radiol. 2025;191:112280.
    PubMed     Abstract available
    
    
    June 2025
30. NATALI T, Kurucz LM, Fusaglia M, Mertens LS, et al
    Automatic prostate volume estimation in transabdominal ultrasound images.
    Eur J Radiol. 2025;191:112274.
    PubMed     Abstract available
    
    
    
31. SINGH D, Chandran A, Panebianco V, Vilaseca J, et al
    MRI capacity assessment for prostate cancer screening in five sites of Europe.
    Eur J Radiol. 2025;190:112235.
    PubMed     Abstract available
    
    
    May 2025
32. SHIN JI, Park KJ, Park MY, Kim MH, et al
    Diagnostic performance of biparametric MRI according to prostate imaging quality (PI-QUAL) version 2: Analysis of Multi-Institutional Data.
    Eur J Radiol. 2025;189:112209.
    PubMed     Abstract available
    
    
    March 2025
33. ZHU W, Tang Y, Qi L, Gao X, et al
    Machine learning models for enhanced diagnosis and risk assessment of prostate cancer with (68)Ga-PSMA-617 PET/CT.
    Eur J Radiol. 2025;186:112063.
    PubMed     Abstract available
    
    
    
34. NIEUWENHOVE SV, Lhommel R, Pasoglou V, Damme JV, et al
    Fast (< 30 min) "All-in-One" whole-body MRI for TNM staging in high-risk prostate cancer (PCa): Feasibility and comparison to (68)Ga-Prostate Specific Membrane Antigen (PSMA)-PET/CT.
    Eur J Radiol. 2025;186:112033.
    PubMed     Abstract available
    
    
    
35. PAUSCH AM, Elsner C, Rupp NJ, Eberli D, et al
    Comparative analysis of TARGET and PI-FAB scores in mpMRI surveillance after HIFU therapy for localized prostate cancer.
    Eur J Radiol. 2025;186:112028.
    PubMed     Abstract available
    
    
    February 2025
36. TOKUDA B, Yamada K, Kozawa N, Takahata A, et al
    Temporal Evolution of multiparametric magnetic resonance imaging findings following lesion-targeted focal microwave tissue coagulation for localized prostate cancer.
    Eur J Radiol. 2025;185:111995.
    PubMed     Abstract available
    
    
    
37. PAUSCH AM, Ghafoor S, Notter R, Benke-Bruderer S, et al
    MRI-based risk stratification for clinically significant prostate cancer detection at biopsy: The value of zonal-specific PSA density and PSHS.
    Eur J Radiol. 2025;184:111982.
    PubMed     Abstract available
    
    
    
38. WALTER-RITTEL TC, Frisch A, Hamm CA, Baumgartner GL, et al
    Automated 24-sector grid-map algorithm for prostate mpMRI improves precision and efficacy of prostate lesion location reporting.
    Eur J Radiol. 2025;183:111897.
    PubMed     Abstract available
    
    
    December 2024
39. PONSIGLIONE A, Stanzione A, Minieri A, Musella R, et al
    Impact of software-assisted structured reporting on radiology residents approaching prostate MRI.
    Eur J Radiol. 2024;183:111889.
    PubMed     Abstract available
    
    
    
40. ASFUROGLU U, Asfuroglu BB, Ozer H, Inan MA, et al
    A comparative analysis of techniques for measuring tumor contact length in predicting extraprostatic extension.
    Eur J Radiol. 2024;181:111753.
    PubMed     Abstract available
    
    
    October 2024
41. BAYERL N, Adams LC, Cavallaro A, Bauerle T, et al
    Assessment of a fully-automated diagnostic AI software in prostate MRI: Clinical evaluation and histopathological correlation.
    Eur J Radiol. 2024;181:111790.
    PubMed     Abstract available
    
    
    
42. KLEIBURG F, de Geus-Oei LF, Luelmo SAC, Spijkerman R, et al
    PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients.
    Eur J Radiol. 2024;181:111774.
    PubMed     Abstract available
    
    
    September 2024
43. PONSIGLIONE A, Cereser L, Spina E, Mannacio L, et al
    PI-QUAL version 2: A Multi-Reader reproducibility study on multiparametric MRI from a tertiary referral center.
    Eur J Radiol. 2024;181:111716.
    PubMed     Abstract available
    
    
    August 2024
44. YADAV D, Dutruel SP, O'Dwyer E, Ricaurte-Fajardo A, et al
    PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer.
    Eur J Radiol. 2024;180:111711.
    PubMed     Abstract available
    
    
    
45. BECKER AS, Woo S, Leithner D, Tong A, et al
    The "Hungry Judge" effect on prostate MRI reporting: Chronobiological trends from 35'004 radiologist interpretations.
    Eur J Radiol. 2024;179:111665.
    PubMed     Abstract available
    
    
    June 2024
46. KLUCKERT J, Hotker AM, Da Mutten R, Konukoglu E, et al
    AI-based automated evaluation of image quality and protocol tailoring in patients undergoing MRI for suspected prostate cancer.
    Eur J Radiol. 2024;177:111581.
    PubMed     Abstract available
    
    
    April 2024
47. FRANSEN SJ, Roest C, Van Lohuizen QY, Bosma JS, et al
    Using deep learning to optimize the prostate MRI protocol by assessing the diagnostic efficacy of MRI sequences.
    Eur J Radiol. 2024;175:111470.
    PubMed     Abstract available
    
    
    
48. PAUSCH AM, Elsner C, Rupp NJ, Eberli D, et al
    MRI-based monitoring of prostate cancer after HIFU: Inter-reader agreement and diagnostic performance of the PI-FAB score.
    Eur J Radiol. 2024;175:111463.
    PubMed     Abstract available
    
    
    March 2024
49. QUENTIN M, Boschheidgen M, Radtke JP, Spohn F, et al
    MRI in-bore biopsy following MRI/US fusion-guided biopsy in patients with persistent suspicion of clinically significant prostate cancer.
    Eur J Radiol. 2024;175:111436.
    PubMed     Abstract available
    
    
    January 2024
50. GIGANTI F, Asbach P
    The backbone of prostate MRI: Technical acquisition and image quality.
    Eur J Radiol. 2024;172:111320.
    PubMed    
    
    
    December 2023
51. REN X, Nur Salihin Yusoff M, Hartini Mohd Taib N, Zhang L, et al
    (68)Ga-prostate specific membrane antigen-11 PET/CT versus multiparametric MRI in the detection of primary prostate cancer: A systematic review and head-to-head comparative meta-analysis.
    Eur J Radiol. 2023;170:111274.
    PubMed     Abstract available
    
    
    
52. HARTH C, De Vulder N, Hermie L, Vanlangenhove P, et al
    Stereotactic transgluteal prostatic biopsy using Cone-Beam CT navigation and prebiopsy MRI image fusion in a patient without rectal access.
    Eur J Radiol. 2023;170:111265.
    PubMed    
    
    
    
53. KHAN A, Moore CM, Minhaj Siddiqui M
    Prostate MRI and image quality: The urologist's perspective.
    Eur J Radiol. 2023;170:111255.
    PubMed     Abstract available
    
    
    
54. WENDEROTT K, Krups J, Luetkens JA, Gambashidze N, et al
    Prospective effects of an artificial intelligence-based computer-aided detection system for prostate imaging on routine workflow and radiologists' outcomes.
    Eur J Radiol. 2023;170:111252.
    PubMed     Abstract available
    
    
    November 2023
55. PAUSCH AM, Ghafoor S, Kluckert J, Rupp NJ, et al
    Risk factors for prostate cancer in men with false-negative mpMRI: A retrospective single center cohort study of image quality scores and clinical parameters.
    Eur J Radiol. 2023;170:111227.
    PubMed     Abstract available
    
    
    
56. AGGARWAL P, Singh H, Das CK, Mavuduru RS, et al
    Potential role of (68)Ga-PSMA PET/CT in metastatic renal cell cancer: A prospective study.
    Eur J Radiol. 2023;170:111218.
    PubMed     Abstract available
    
    
    
57. REHMAN I, Pang E, Harris AC, Chang SD, et al
    Bi-parametric prostate MRI with a recall system for contrast enhanced imaging: Improving accessibility while maintaining quality.
    Eur J Radiol. 2023;169:111186.
    PubMed     Abstract available
    
    
    
58. FLEMING H, Dias AB, Talbot N, Li X, et al
    Inter-reader variability and reproducibility of the PI-QUAL score in a multicentre setting.
    Eur J Radiol. 2023;168:111091.
    PubMed     Abstract available
    
    
    October 2023
59. AL-MONAJJED R, Radtke JP, Thomas M, Boschheidgen M, et al
    Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral zone in men without prostate cancer.
    Eur J Radiol. 2023;169:111151.
    PubMed     Abstract available
    
    
    
60. ZHANG KS, Mayer P, Glemser PA, Tavakoli AA, et al
    Are T2WI PI-RADS sub-scores of transition zone prostate lesions biased by DWI information? A multi-reader, single-center study.
    Eur J Radiol. 2023;167:111026.
    PubMed     Abstract available
    
    
    
61. SABBAH M, Gutierrez P, Puech P
    MA-QC: Free online software for prostate MR quality control and PI-QUAL assessment.
    Eur J Radiol. 2023;167:111027.
    PubMed     Abstract available
    
    
    September 2023
62. SINGH S, Giganti F, Dickinson L, Rogers H, et al
    Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts.
    Eur J Radiol. 2023;168:111109.
    PubMed     Abstract available
    
    
    
63. YILMAZ EC, Harmon SA, Belue MJ, Merriman KM, et al
    Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI.
    Eur J Radiol. 2023;168:111095.
    PubMed     Abstract available
    
    
    August 2023
64. THIJSSEN LCP, de Rooij M, Barentsz JO, Huisman HJ, et al
    Radiomics based automated quality assessment for T2W prostate MR images.
    Eur J Radiol. 2023;165:110928.
    PubMed     Abstract available
    
    
    
65. DEIVASIGAMANI S, Kotamarti S, Adams ES, Seguier D, et al
    Reconciling discordance between PI-RADS 4 lesions and targeted biopsy: Early experience of a multidisciplinary quality improvement protocol with PI-RADS 4 subcategorization.
    Eur J Radiol. 2023;165:110929.
    PubMed     Abstract available
    
    
    June 2023
66. URSPRUNG S, Herrmann J, Joos N, Weiland E, et al
    Accelerated diffusion-weighted imaging of the prostate using deep learning image reconstruction: A retrospective comparison with standard diffusion-weighted imaging.
    Eur J Radiol. 2023;165:110953.
    PubMed     Abstract available
    
    
    
67. ZHANG KS, Neelsen CJO, Wennmann M, Glemser PA, et al
    Same-day repeatability and Between-Sequence reproducibility of Mean ADC in PI-RADS lesions.
    Eur J Radiol. 2023;165:110898.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum